1-2 of 2
Hans Hasselbalch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination therapy with ruxolitinib and pegylated interferon alfa-2a in newly diagnosed patients with polycythemia vera

Clinical Trials & Observations
Anders Lindholm Sørensen, Vibe Skov, Lasse Kjær, Mads Emil Bjørn, Christina Schjellerup Eickhardt-Dalbøge, Morten Kranker Larsen, Claus H Nielsen, Carsten Thomsen, Lise Mette Rahbek Gjerdrum, Trine Alma Knudsen, Christina Ellervik, Ulrik Malthe Overgaard, Christen Lykkegaard Andersen, Hans Hasselbalch
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5416–5425.
https://doi.org/10.1182/bloodadvances.2024013170
Published: 2024
Includes: Supplemental data
Journal Articles

Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study

Clinical Trials & Observations
Vikas Gupta, Denise Wolleschak, Hans Hasselbalch, Alessandro Maria Vannucchi, Steffen Koschmieder, Francisco Cervantes, Yang Li, Tuochuan Dong, Monika Wroclawska, Savita Bharathy, Claire Harrison
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3063–3071.
https://doi.org/10.1182/bloodadvances.2019001212
Published: 2020
Includes: Supplemental data